Research article Open access
Empagliflozin Use in Cardiac Transplant Patients: Real-world experience from Saudi Arabia
Objectives: Sodium-glucose transport protein 2 (SGLT2) inhibitors are used in the treatment of patients with type 2 diabetes. Besides their beneficial metabolic effects, such as lowering glycated haemoglobin, body weight and blood pressure, these agents have shown favourable and protective effects on both the heart and …